Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study

Editorial reading guide · Kindness

What support around a teen chatbot matters as much as the chatbot itself?

Tests a constrained therapeutic chatbot inside an existing care relationship. At four weeks, depression scores declined by 3.3 points in the app group and 2 in the wait-list group, but this tiny pilot could not establish effectiveness. Teens and parents generally found it usable; substantial clinical safety review was part of the study.

Study context

18 adolescents randomized in a US pediatric primary-care network; 17 analyzed (10 app, 7 wait-list); 13 primary-care providers interviewed.

Age / stage: 13–17 years

Read with three questions

1. What can the small symptom changes tell us about feasibility, and why do they not establish treatment efficacy?
2. How did usual primary care, concurrent medication and rapid psychiatrist review shape both groups’ experiences?
3. Which adolescents were largely missing from the predominantly female, White and privately insured sample?

Keep the limits in view

Very small, homogeneous sample; pandemic recruitment, concurrent antidepressants and high-quality usual care limit comparisons. Safety included individualized review and consultation within 24 hours for clinically significant suicidal ideation, so safety findings cannot be transferred to unsupervised consumer use. No long-term effectiveness was established.